Serif Biomedicines Presents Data at ASGCT 2026 Demonstrating the Potential of Modified DNA as a New Class of Genetic Medicines May 12 '26
Flagship Pioneering Launches Serif Biomedicines to Establish Modified DNA as a New Biotechnology Apr 21 '26